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Enantiomerically pure (R)-1-(1-phenylethyl)imidazoles 4a,b can be pre pared con ve -
niently from α-(hydroxyimino)ke tones 1, (R)-1-phenylethylamine and form al de hyde,
fol lowed by deoxygenation with Raney-Ni. Sim i larly, the re ac tion with (R,R)-trans-cyc -
lo hex ane-1,2-diamine yields enantiomerically pure (R,R)-trans-1,1′-cyc lo hex -
ane-1,2-diyl)imidazoles 4c,d. Alkylation of these imidazole de riv a tives with
alkylbromides leads to the cor re spond ing 3-alkylimidazolium bro mides 6 and 8, re spec -
tively, which on treat ment with so dium tetrafluoroborate are trans formed into the cor re -
spond ing tetrafluoroborates 7 and 9. Whereas some of the imidazolium salts 7 show
prop er ties of chiral ionic liq uids, the bis-imidazolium tetrafluoroborates 9 are high-melt -
ing crys tal line ma te ri als.
Key  words: imidazole N-oxides, imidazolium salts, ionic liquids, X-ray crystallog ra phy
In the last de cade, an in creas ing num ber of stud ies aimed at the syn the sis of
imidazolium-based ionic liq uids, their physico-chem i cal prop er ties and di verse ap -
pli ca tions in or ganic syn the sis have been car ried out [1,2]. With re spect to
stereoselective syn the ses, chiral ionic liq uids (CILs) are of spe cial in ter est. For this
rea son, the search for newly de signed chiral imidazole de riv a tives, which ful fill the
re quire ments of ionic liq uids, es pe cially the so-called ‘room-tem per a ture chiral ionic 
liq uids’ (RTCILs), is a chal leng ing sub ject [2c,d].
In some re cent pa pers, dif fer ent meth ods for the syn the sis of op ti cally ac tive
imidazole de riv a tives were de scribed. The chiral build ing blocks with spe cial im por -
tance in this con text are α-amino acid de riv a tives [3–5], 1-phenylethylamine [4,6,7]
and β-aminoalcohols [8]. In ad di tion, enantiomerically pure trans-cyc lo hex -
ane-1,2-diamine was used for the first time to pre pare op ti cally ac tive bis-imidazoles
[9]. To date, the prep a ra tion of op ti cally ac tive ionic liq uids was mainly based on the
ex plo ra tion of α-amino acid de riv a tives as well as 1-phenylethylamine.
Pol ish J. Chem., 83, 1105–1114 (2009) OR GANIC CHEM IS TRY
*   Authors for correspondence; e-mail: gmloston@uni.lodz.pl, heimgart@oci.uzh.ch
**  Part of the planned PhD thesis of P.M., University of £ódŸ.  
***  Part of the Diploma thesis of R.T., University of £ódŸ, 2008.
The goal of the pres ent work was the syn the sis of new imidazolium salts de rived
from 1,4,5-trisubstituted imidazoles and bis-imidazoles as po ten tial chiral ionic liq uids.
RE SULTS AND DIS CUS SION
The syn the sis of imidazole de riv a tives 4 was car ried out us ing the well es tab -
lished method of the con den sa tion of α-(hydroxyimino)ke tones 1 with amines 2 and
form al de hyde to give imidazole 3-ox ides 3 [7,9] (Scheme 1). The sub se quent
deoxygenation with Raney-Ni at room tem per a ture af forded the de sired imidazoles 4. 
The prep a ra tion of op ti cally ac tive imidazoles 4 re quired op ti cally ac tive amino com -
po nents, i.e. (R)- or (S)-1-phenylethylamine (2a) and (R,R)- or (S,S)-trans-cyc lo hex -
ane-1,2-diamine (2b), re spec tively. The op ti cal pu rity of the N-ox ides 3a-d was
con firmed by 1H-NMR spec tros copy af ter the ad di tion of the chiral solvating agent
(R)-(tert-butyl)(phenyl)phosphonothioic acid, as de scribed in pre vi ous pa pers [7,9].
Sup ple men tary to our ear lier stud ies on the struc ture of chiral bis-(imidazole
N-ox ides), the enantiomerically pure prod ucts (R,R)- and (S,S)-3c were ob tained as
sin gle crys tals suit able for an X-ray struc ture de ter mi na tion. In both cases, the ab so -
lute con fig u ra tion was de ter mined in de pend ently by the dif frac tion ex per i ment and
cor re sponded to the ab so lute con fig u ra tion of the used trans-cyclo hexyl-
 1,2-diamine (2b).
1106 G. Mlostoñ et al.
 
R N
OR
OH
+
Ph
NH2
+ CH2O
a) MeOH
     reflux
       or
b) AcOH
       r.t.
N
N
R O
R
Ph
Raney-Ni
EtOH, r.t. N
N
R
R
Ph
1a R = Me
  b R = Ph
(R)-2a
(R)-3a R = Me
        b R = Ph
(R)-4a R = Me
        b R = Ph
R N
OPh
OH
+
1b R = Ph
  c R = Me
2
H2N NH2
+ 2 CH2O
AcOH
r.t.
N N
N NR
Ph
R
Ph
O O
Raney-Ni
EtOH, r.t.
(R,R)-3c R = Ph
            d R = Me
(R,R)-2b
N N
N NR
Ph
R
Ph
(R,R)-4c R = Ph
            d R = Me
Scheme 1
In each case, the asym met ric unit con tains two mol e cules of 3c plus two mol e -
cules of CH2Cl2. In each struc ture, both in de pend ent mol e cules of 3c are of the same
enantiomorph, i.e. they both have the (R,R)- or (S,S)-con fig u ra tion, re spec tively.
Their con for ma tions dif fer only in slight twists of the ori en ta tions of some phenyl
rings. The cyc lo hex ane rings have chair con for ma tions with the heterocyclic
substitutents in equa to rial po si tions. In each mol e cule, the N-ox ide groups are ori -
ented anti, i.e. the mol e cules have ap prox i mate non-crys tal lo graphic C2 sym me try.
The N–O bond lengths range from 1.319(5)–1.331(4) Å, which is quite nor mal for ar -
o matic N-ox ides. The slightly lon ger N–O bonds in the pre vi ously re ported
imidazole N-ox ides (1.345(1), 1.342(3) Å [8b], and 1.338(2) [9], re spec tively) may
be the re sult of the hy dro gen-bond ing with a wa ter mol e cule.
The 1,4,5-trisubstituted imidazoles 4a,b were alkylated with alkylbromides
5a–d ei ther in boil ing acetonitrile us ing ap prox i mately stoichiometric amounts of 5
or in an ex cess of the alkylating agent. A com par i son of the re ac tion times (TLC con -
trol) in di cated that the 4,5-dimethyl de riv a tive (R)-4a un der went the alkylation more
eas ily than the 4,5-di phen yl an a logue (R)-4b. For ex am ple, the alkylation with ethyl
bro mide as the sol vent was com plete af ter 24 h in the case of (R)-4a and only af ter 87
h in the case of (R)-4b. The crude bro mides 6, iso lated in good yields as crys tal line
ma te ri als, were con verted di rectly into the tetrafluoroborates 7 by treat ment with
NaBF4 in ac e tone at room tem per a ture (Scheme 2).
In ac cor dance with the ex pected ten dency [2c,5b], the Br– → BF4-  ex change re -
sulted in the low er ing of the melt ing point of the cor re spond ing imidazolium salt, but
only in the case of 7c was a liq uid prod uct ob tained. In two other cases, i.e. 7d and 7f,
the melt ing points were de ter mined to be 60–62 and 86–88°C, re spec tively, and,
there fore, these prod ucts can also be con sid ered as suit able ma te ri als for ionic liq uids.
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Fig ure 1. ORTEP plots [10] of the mo lec u lar struc tures of one of the two sym met ri cally in de pend ent
mol e cules in each of a) (R,R)-3c and b) (S,S)-3c (ar bi trary num ber ing of the at oms, 50% prob a -
bil ity el lip soids).
 
a) b)
The at tempted alkylation ex per i ments with the bis-(4,5-diphenylimidazole)
(R,R)-4c and ethyl- as well as butylbromide were in vain. On the other hand, (R,R)-4d
was suc cess fully con verted into the bis-imidazolium dibromides 8a,b by treat ment
with butyl- or hexyl bro mide in boil ing acetonitrile (Scheme 3). In this case, both
prod ucts were ob tained as crys tal line ma te ri als with high melt ing points, even af ter
the re place ment of the Br– ions by BF4-  (9a: 184–186°C, 9b: 174–176°C).
The struc ture of the bis-imidazolium bis-tetrafluoroborate 9a was de ter mined
unambigously by X-ray crys tal log ra phy and is de picted in Fig ure 2. The space group
P21 per mits the com pound in the crys tal to be enantiomerically pure, but the ab so lute
con fig u ra tion of the mol e cule has not been de ter mined. The en an tio mer used in the
re fine ment was based on the pro posed (R,R)-con fig u ra tion of the mol e cule, which
has been pre pared from (R,R)-3d via (R,R)-4d. The asym met ric unit con tains one
di-cat ion, two an ions, and one wa ter mol e cule. One of the butyl groups is dis or dered
over two con for ma tions. The an ions also show in di ca tions of slight dis or der, but their 
dis or der has not been mod eled. The wa ter mol e cule forms a hy dro gen bond with an
F-atom from each of the sym me try in de pend ent an ions.
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CON CLU SIONS
The re sults pre sented in this pa per show that the eas ily ac ces si ble, enantio -
merically pure 1-phenylethylamine ((R)- or (S)-2a) and trans- cyclo hexyl- 1,2-
 diamine ((R,R)-2b) can be uti lized for the prep a ra tion of 1,4,5-trisubstituted
imidazoles 4 via deoxygenation of the ini tially formed N-ox ides 3. The al ky la tions of 
imidazoles 4 with lin ear alkyl bro mides, fol lowed by the ex change of the an ion, lead
to imidazolium tetrafluoroborates which were ex pected to dis play prop er ties of ionic
liq uids. Whereas in the se ries of the op ti cally ac tive 1-phenylethylamine de riv a tives,
the prod ucts 7c,d and f are prom is ing can di dates to be used as chiral ionic liq uids, the
bis-imidazolium salts 8 and 9 are high melt ing crys tal line ma te ri als. Nev er the less, all 
of the ob tained imidazolium salts can po ten tially be used as lig ands for the pur pose of 
stereocontrolled or ganic syn the sis.
EX PER I MEN TAL
1. Gen eral. Melt ing points were de ter mined on a Melt-Temp. II ap pa ra tus (Aldrich) in cap il lar ies
and are un cor rected. IR spec tra were mea sured on a NEXUS FT-IR spectrophotometer in KBr or as a film
in cm–1. 1H-NMR spec tra were re corded on a Tesla BS 687 (80 MHz) or VARIAN GEM INI 200BB (200
MHz) in stru ment in CDCl3 or CD3OD as the sol vent and with TMS (δ = 0 ppm) as an in ter nal stan dard.
13C-NMR spec tra were re corded on a VARIAN GEM INI 200BB in stru ment in CDCl3 as the sol vent.
Spectropolarimetric anal y ses were car ried out on a KRUSS OPTRONIC GER MANY in stru ment (589
nm).
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Fig ure 2. ORTEP plot [10] of the mo lec u lar struc ture of the di-cat ion of (R,R)-9a (con for ma tion A; with
30% prob a bil ity el lip soids; ar bi trary num ber ing of the at oms; H-at oms omit ted for clar ity).
2. Start ing ma te ri als. (R)-1-Phenylethylamine ((R)-2a), form al de hyde, alkylbromides 5 (ethyl,
butyl, hexyl, octyl), and so dium tetrafluoroborate were com mer cially avail able (Aldrich).
α-(Hydroxyimino)ke tones 1 were ob tained ac cord ing to known pro to cols: bu tane-2,3-dione monooxime
(1a) [11a] and 1-phenylpropane-1,2-dione 2-oxime (1c) [11b] by nitrosation of the cor re spond ing ke tones 
us ing iso-amyl ni trite, 1,2-diphenylethane-1,2-dione monooxime (1b, benzil monooxime) [11c] from
dibenzoyl and hydroxylamine hy dro chlo ride. (R,R)-trans-1,2-Diaminocyclohexane ((R,R)-2b) was ob -
tained by res o lu tion of the racemic mix ture ac cord ing to a known pro to col [9]. Imidazole 3-ox ides 3 and
imidazoles 4 were ob tained ac cord ing to pre vi ously re ported pro to cols [7,9].
3. Syn the sis of op ti cally ac tive imidazolium bro mides 6.
a) In ethyl bro mide with out sol vent. (R)-1-(1-Phenylethyl)-4,5-dimethyl-1H-imidazole ((R)-4a) or
(R)-1-(1-phenylethyl)-4,5-di phen yl-1H-imidazole ((R)-4b) (1 mmol) was dis solved in ethyl bro mide (2
ml), and the so lu tion was heated to re flux un til the end of the re ac tion (TLC con trol). Then, the mix ture
was con cen trated and the crude prod uct was washed with di ethyl ether.
(R)-1-(1-Phenylethyl)-3-ethyl-4,5-dimethyl-1H-imidazolium bro mide ((R)-6a)*. Re ac tion time: 24
h. Yield: 226 mg (73%). Col or less crys tals. 1H-NMR (CDCl3): 1.59 (t, JH-H = 6.4 Hz, CH3CH2); 2.06 (d,
JH-H = 6.4 Hz, CH3CH); 2.12, 2.24 (2s, 2 CH3); 4.48 (q, JH-H = 6.4 Hz, CH2N); 5.65 (q, JH-H = 6.4 Hz,
CH3CH); 7.16–7.52 (m, 5 CHarom); 10.62 (s, HC(2)).
(S)-1-(1-Phenylethyl)-3-ethyl-4,5-di phen yl-1H-imidazolium bro mide ((S)-6e)**. Re ac tion time: 87
h. Yield: 346 mg (80%). Col or less crys tals. 1H-NMR (CDCl3): 1.48 (t, JH-H = 6.4 Hz, CH3CH2); 2.14 (d,
JH-H = 6.4 Hz, CH3CH); 4.54 (q, JH-H = 6.4 Hz, CH2N); 5.39 (q, JH-H = 6.4 Hz, CH3CH); 6.61–7.61 (m, 15
CHarom); 11.17 (s, HC(2)).
b) In boil ing acetonitrile. (R)-1-(1-Phenylethyl)-4,5-dimethyl-1H-imidazole ((R)-4a) or
(R)-1-(1-phenylethyl)-4,5-di phen yl-1H-imidazole ((R)-4b) (1 mmol) and an alkyl bro mide (1 mmol)
were dis solved in acetonitrile (3 ml), and the so lu tion was heated to re flux un til the end of the re ac tion
(TLC con trol). Then, the mix ture was con cen trated and the crude prod uct was washed with pe tro leum
ether and then with di ethyl ether.
(R)-1-(1-Phenylethyl)-3-butyl-4,5-dimethyl-1H-imidazolium bro mide ((R)-6b). Re ac tion time: 10 h.
Yield: 320 mg (95%). Col or less crys tals. 1H-NMR (CDCl3): 0.95 (t, JH-H = 6.4 Hz, CH3CH2); 1.00–2.05
(m, 2 CH2); 1.99 (d, JH-H = 6.4 Hz, CH3CH); 2.08, 2.20 (2s, 2 CH3); 4.39 (t, JH-H = 6.4 Hz, CH2N); 5.61 (q,
JH-H = 6.4 Hz, CH3CH); 7.04–7.52 (m, 5 CHarom); 10.68 (s, HC(2)).
(R)-1-(1-Phenylethyl)-3-hexyl-4,5-dimethyl-1H-imidazolium bro mide ((R)-6c). Re ac tion time: 15
h. Yield: 354 mg (97%). Col or less crys tals. 1H-NMR (CDCl3): 0.92 (t, JH-H = 6.4 Hz, CH3CH2); 1.16–1.90 
(m, 4 CH2); 1.92 (d, JH-H = 6.4 Hz, CH3CH); 2.10, 2.20 (2s, 2 CH3); 4.44 (t, JH-H = 6.4 Hz, CH2N); 5.60 (q,
JH-H = 6.4 Hz, CH3CH); 7.10–7.60 (m, 5 CHarom); 10.72 (s, HC(2)).
(R)-1-(1-Phenylethyl)-3-octyl-4,5-dimethyl-1H-imidazolium bro mide ((R)-6d). Re ac tion time: 13 h.
Yield: 322 mg (82%). Col or less crys tals. 1H-NMR (CDCl3): 0.84 (t, JH-H = 6.4 Hz, CH3CH2); 1.04–1.80
(m, 6 CH2); 1.86 (d, JH-H = 6.4 Hz, CH3CH); 2.10, 2.20 (2s, 2 CH3); 4.36 (t, JH-H = 6.4 Hz, CH2N); 5.64 (q,
JH-H = 6.4 Hz, CH3CH); 7.10–7.50 (m, 5 CHarom); 10.60 (s, HC(2)).
c) In butyl bro mide with out sol vent. The imidazole (R)-4b was heated to 100°C in ex cess butyl bro -
mide used as the sol vent. Then, the mix ture was con cen trated and the crude prod uct was washed with di -
ethyl ether.
(R)-1-(1-Phenylethyl)-3-butyl-4,5-di phen yl-1H-imidazolium bro mide ((R)-6f). Re ac tion time: 15 h. 
Yield: 244 mg (53%). Col or less crys tals. 1H-NMR (CDCl3): 0.79 (t, JH-H = 6.4 Hz, CH3CH2); 1.04–2.01
(m, 2 CH2); 2.16 (d, JH-H = 6.4 Hz, CH3CH); 4.50 (t, JH-H = 6.4 Hz, CH2N); 5.38 (q, JH-H = 6.4 Hz, CH3CH); 
6.91–7.61 (m, 15 CHarom); 11.20 (s, CH(2)).
4. Syn the sis of op ti cally ac tive bis-imidazolium dibromides 8. (R,R)-trans-1,1′-(Cyc lo hex -
ane-1,2-diyl)bis(4-methyl-5-phenylimidazole) ((R,R)-4d, 0.5 mmol) and an alkyl bro mide 5 (1 mmol)
were dis solved in acetonitrile (6 ml), and the so lu tion was heated to re flux un til the end of the re ac tion
(TLC con trol). Then, the mix ture was con cen trated and the crude prod uct was washed with pe tro leum
ether and then with di ethyl ether.
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*    The ethylation was also carried out with (S)-4a (yield of (S)-6a: 79%).
**   The ethylation was also carried out with (S)-4b.
(R,R)-trans-1,1’-(Cyc lo hex ane-1,2-diyl)bis(3-butyl-4-methyl-5-phenylimidazolium) dibromide
((R,R)-8a). Re ac tion time: 50–120 h. Yield: 204 mg (61%). Col or less crys tals. 1H-NMR (CDCl3): 1.00 (t,
JH-H = 6.4 Hz, 2 CH3CH2); 1.25–2.10 (m, 4 CH2, 4 CH2 cHex); 2.17 (s, 2 CH3); 4.19 (t, JH-H = 6.4 Hz, 2
CH2N); 5.04–5.40 (m, 2 CH cHex); 7.00–7.60 (m, 10 CHarom); 10.60 (s, 2 HC(2)).
(R,R)-trans-1,1′-(Cyc lo hex ane-1,2-diyl)bis(3-hexyl-4-methyl-5-phenylimidazolium) dibromide
((R,R)-8b). Re ac tion time: 100 h. Yield: 250 mg (69%). Col or less crys tals. 1H-NMR (CDCl3): 0.96 (t,
JH-H  = 6.4 Hz, 2 CH3CH2); 1.16–2.10 (m, 8 CH2, 4 CH2 cHex); 2.20 (s, 2 CH3); 4.20 (t, JH-H = 6.4 Hz, 2
CH2); 5.03–5.50 (m, 2 CH cHex); 6.09–7.70 (m, 10 CHarom); 10.55 (s, 2 HC(2)).
5. Syn the sis of op ti cally ac tive imidazolium tetrafluoroborates 7. To a so lu tion of an imidazolium 
bro mide (R)-6 (1 mmol) in ac e tone (8 ml), so dium tetrafluoroborate (1 mmol) was added, and the so lu tion
was stirred at room tem per a ture for 24 h. Then, the mix ture was fil tered through Al2O3 and con cen trated.
The crude prod uct was washed with di ethyl ether [12].
(R)-1-(1-Phenylethyl)-3-ethyl-4,5-dimethyl-1H-imidazolium tetrafluoroborate ((R)-7a). Yield: 310 
mg (98%). Col or less crys tals. M.p. 156–158°C. IR (KBr, cm–1): 3172m, 3121m, 2977m, 1633m, 1560s,
1495s, 1450s, 1401m, 1340m, 1239s, 1192m, 1084s, 1070s, 765m, 704s, 629m, 553m. 1H-NMR (CDCl3):
1.50 (t, JH-H = 7.3 Hz, CH3CH2); 1.92 (d, JH-H = 6.8 Hz, CH3CH); 2.07, 2.23 (2s, 2 CH3); 4.25 (q, JH-H = 7.3
Hz, CH2N); 5.46 (q, JH-H = 6.8 Hz, CH3CH); 7.10–7.50 (m, 5 CHarom); 8.97 (s, HC(2)). 13C-NMR
(CDCl3): 7.9, 8.6 (2 CH3); 15.0 (CH3CH2); 21.3 (CH3CH); 42.5 (CH3CH2); 58.1 (CH3CH); 126.2, 128.7,
129.3 (5 CHarom); 127.1, 127.4 (C(4), C(5)); 132.5 (C(2)); 138.6 (Carom). [α] D20 = –80 (c 0.2, CH2Cl2).
(R)-1-(1-Phenylethyl)-3-butyl-4,5-dimethyl-1H-imidazolium tetrafluoroborate ((R)-7b). Yield:
310 mg (90%). Col or less crys tals. M.p. 134–136°C. IR (KBr, cm–1): 2955s, 1632m, 1557m, 1458m,
1249m, 1195m, 1084s, 769m, 710m, 522m, 533m. 1H-NMR (CDCl3): 0.93 (t, JH-H = 7.2 Hz, CH3CH2);
1.13–1.83 (m, 2 CH2); 1.93 (d, JH-H = 7.0 Hz, CH3CH); 2.03, 2.17 (2s, 2 CH3); 4.17 (t, JH-H = 7.2 Hz,
CH2N); 5.53 (q, JH-H = 7.0 Hz, CH3CH); 7.00–7.60 (m, 5 CHarom); 9.00 (s, HC(2)). 13C-NMR (CDCl3):
7.8, 8.3 (2 CH3); 13.1 (CH3CH2); 19.1, 31.6, 46.9 (3 CH2); 21.2 (CH3CH); 57.8 (CH3CH); 125.8, 128.4,
129.1 (5 CHarom); 127.1, 127.4 (C(4), C(5)); 132.5 (C(2)); 138.5 (Carom). [α] D20 = –78 (c 0.2, CH2Cl2).
(R)-1-(1-Phenylethyl)-3-hexyl-4,5-dimethyl-1H-imidazolium tetrafluoroborate ((R)-7c). Yield: 305
mg (82%). Yel low liq uid. IR (film, cm–1): 3155m, 3084m, 2932s, 2264m, 1700m, 1633m, 1560s, 1496m,
1456s, 1243s, 1193m, 1038s, 915s, 765m, 730s, 705m. 1H-NMR (CDCl3): 0.90 (t, CH3CH2); 1.10–1.80 (m,
4 CH2); 1.83 (d, JH-H = 7.0 Hz, CH3CH); 2.07, 2.20 (2s, 2 CH3); 4.17 (t, JH-H = 7.7 Hz, CH2N); 5.43 (q, JH-H =
7.0 Hz, CH3CH); 7.00–7.50 (m, 5 CHarom); 9.00 (s, HC(2)). 13C-NMR (CDCl3): 8.0, 8.6 (2 CH3); 13.7
(CH3CH2); 21.4 (CH3CH); 22.2, 25.6, 29.8, 30.9, 47.3 (5 CH2); 58.0 (CH3CH); 126.0, 128.6, 129.3 (5
CHarom); 127.1, 127.4 (C(4), C(5)); 132.9 (C(2)); 138.5 (Carom). [α]D20 = –65.5 (c 0.2, CH2Cl2).
(R)-1-(1-Phenylethyl)-3-octyl-4,5-dimethyl-1H-imidazolium tetrafluoroborate ((R)-7d). Yield: 228
mg (57%). Col or less crys tals. M.p. 60–62°C. IR (KBr, cm–1): 2928s, 2856m, 1632m, 1558m, 1456m, 1084s, 
765m, 707m, 533m, 522m. 1H-NMR (CDCl3): 0.83 (t, CH3CH2); 1.10–1.76 (m, 6 CH2); 1.77 (d, JH-H = 7.1
Hz, CH3CH); 2.07, 2.20 (2s, 2 CH3); 4.20 (t, JH-H = 6.8 Hz, CH2N); 5.47 (q, JH-H = 7.1 Hz, CH3CH);
7.10–7.60 (m, 5 CHarom); 9.00 (s, HC(2)). 13C-NMR (CDCl3): 7.9, 8.4 (2 CH3); 13.8 (CH3CH2); 21.3
(CH3CH); 22.3, 25.9, 28.7, 28.8, 29.8, 31.4, 47.2 (7 CH2); 57.9 (CH3CH); 125.9, 128.5, 129.2 (5 CHarom);
127.0, 127.4 (C(4), C(5)); 132.7 (C(2)); 138.6 (Carom). [α]D20 = –67 (c 0.2, CH2Cl2).
(S)-1-(1-Phenylethyl)-3-ethyl-4,5-di phen yl-1H-imidazolium tetrafluoroborate ((S)-7e). Yield: 224
mg (51%). Col or less crys tals. M.p. 142–144°C. IR (KBr, cm–1): 2983m, 1557m, 1446m, 1192m, 1083s,
764m, 700s, 533m, 522m. 1H-NMR (CDCl3): 1.40 (t, CH3CH2); 2.00 (d, CH3CH); 4.30 (q, CH2N); 5.40 (q,
CH3CH); 6.90–7.60 (m, 15 CHarom); 9.29 (s, HC(2)). 13C-NMR (CDCl3): 15.2 (CH3CH2); 21.2 (CH3CH);
43.5 (CH3CH2); 58.7 (CH3CH); 124.9, 125.1 (C(4), C(5)); 126.4, 128.7, 128.8, 129.0, 129.1, 130.2, 130.5,
131.0 (15 CHarom); 132.5 (br., 2 Carom); 133.7 (C(2)); 138.7 (Carom). [α]D20 = –12.6 (c 0.2, CH2Cl2).
(R)-1-(1-Phenylethyl)-3-butyl-4,5-di phen yl-1H-imidazolium tetrafluoroborate ((R)-7f). Yield: 445
mg (95%). Col or less crys tals. M.p. 86–88°C. IR (film, cm–1): 3151m, 3065m, 2963m, 2875m, 1555s,
1456s, 1355m, 1281m, 1185s, 1036s, 765m, 734m, 701s, 667s. 1H-NMR (CDCl3): 0.79 (t, CH3CH2);
1.10–1.80 (m, 2 CH2); 2.03 (d, CH3CH); 4.28 (t, CH2N); 5.40 (q, CH3CH); 7.03–7.38 (m, 15 CHarom); 9.30 
(s, HC(2)). 13C-NMR (CDCl3): 13.0, 19.1, 21.1, 31.7, 47.8 (2 CH3, 3 CH2); 58.7 (CH3CH); 124.8, 124.9
(C(4), C(5)); 126.2, 128.6, 128.8, 129.0, 129.1, 130.2, 130.4, 130.9 (15 CHarom); 134.0 (C(2)); 132.3,
132.5, 138.6 (3 Carom). [α] D20 = +59 (c 0.2, CH2Cl2).
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6. Syn the sis of op ti cally ac tive bis-imidazolium bis-tetrafluoroborates 9. To a so lu tion of a
bis-imidazolium dibromide (R,R)-8 (0.5 mmol) in ac e tone (8 ml), so dium tetrafluoroborate (1 mmol) was
added, and the so lu tion was stirred at room tem per a ture for 48 h. Then, the mix ture was fil tered through
Al2O3 and con cen trated. The crude prod uct was washed with di ethyl ether.
(R,R)-trans-1,1 ′-(Cyc lo hex ane-1,2-diyl)bis(3-butyl-4-methyl-5-phenylimidazolium)
bis-tetrafluoroborate ((R,R)-9a): Yield: 297 mg (87%). Col or less crys tals. M.p. 184–186°C. IR (KBr,
cm–1): 2960m, 1629m, 1556m, 1456m, 1063s, 769m, 705m. 1H-NMR (CDCl3): 1.01 (t, 2 CH3CH2);
1.20–2.03 (m, 4 CH2, 4 CH2 cHex); 1.20 (s, 2 CH3); 3.80–4.15 (m, 2 CH2N); 4.53–4.97 (m, 2 CH cHex);
6.90–7.80 (m, 10 CHarom); 8.53 (s, 2 HC(2)). 13C-NMR (CDCl3): 8.1 (2 CH3); 13.4 (2 CH3CH2); 19.6, 23.8,
30.7, 33.1 (br.), 47.8 (10 CH2); 60.5 (br., 2 CH cHex); 124.7 (br., 2 C(4), 2 C(5)); 129.8, 130.6, 130.8 (10
CHarom and 2 HC(2)); 132.5 (br., 2 Carom). [α]D20 = –40 (c 0.2, CH2Cl2).
(R,R)-trans-1,1 ′-(Cyc lo hex ane-1,2-diyl)bis(3-hexyl-4-methyl-5-phenylimidazolium)
bis-tetrafluoroborate ((R,R)-9b): Yield: 329 mg (89%). Col or less crys tals. M.p. 174–176°C. IR (KBr,
cm–1): 2933m, 1628m, 1553m, 1467m, 1084s, 769m, 704m. 1H-NMR (CDCl3): 0.91 (t, 2 CH3CH2);
1.26–2.01 (m, 8 CH2, 4 CH2 cHex); 1.25 (s, 2 CH3); 4.08 (t, 2 CH2N); 4.50–5.00 (m, 2 CH cHex); 6.90–7.70
(m, 10 CHarom); 8.70 (br. s, 2 HC(2)). 13C-NMR (CDCl3): 8.1 (2 CH3); 13.9 (2 CH3CH2); 22.4, 23.9, 26.1,
28.9, 31.04, 32.7, 48.1 (12 CH2); 60.4 (br., 2 CH cHex); 125.3, 125.4 (br., 2 C(4), 2 C(5)); 129.6, 130.8,
130.9 (10 CHarom and 2 HC(2)); 131.1 (br., 2 Carom). [α]D20 = –40 (c 0.2, CH2Cl2).
7. X-ray crys tal struc ture de ter mi na tion of (R,R)- and (S,S)-3c and (R,R)-9a (see Ta ble 1 and Figs.
1–2).* All mea sure ments were made on a Nonius KappaCCD diffractometer [13] us ing graph ite-monochromated
MoKα ra di a tion (λ  0.71073 Å) and an Ox ford Cryosystems Cryostream 700 cooler. Data re duc tion was per formed
with HKL Denzo and Scalepack [14]. The in ten si ties were cor rected for Lo rentz and po lar iza tion ef fects, and in the
cases of (R,R)- and (S,S)-3c, ab sorp tion cor rec tions based on the multi-scan method [15] were ap plied.  Equiv a lent
re flec tions, other than Friedel pairs, were merged for (R,R)- and (S,S)-3c, while Friedel pairs were also merged for
(R,R)-9a.  Data col lec tion and re fine ment pa ram e ters are given in Ta ble 1, and views of the mol e cules are shown in
Figs. 1 and 2. The struc tures were solved by di rect meth ods us ing SIR92 [16], which re vealed the po si tions of all
non-H-at oms. The asym met ric units of (R,R)- and (S,S)-3c con tain two mol e cules of the heterocyclic com pound
plus two mol e cules of CH2Cl2. The atomic co or di nates of the mol e cules were tested care fully for a re la tion ship
from a higher sym me try space group us ing the pro gram PLATON [17], but none could be found. In the case of
(R,R)-9a, the asym met ric unit con tains one di-cat ion, two BF4- ions, and one wa ter mol e cule. One of the butyl
groups is dis or dered over two con for ma tions. Two sets of over lap ping po si tions were de fined for the at oms of this
butyl group and the site oc cu pa tion fac tor of the ma jor con for ma tion re fined to 0.613(11). Sim i lar ity re straints were
ap plied to the chem i cally equiv a lent bond lengths and an gles in volv ing all dis or dered C-at oms, while neigh bor ing
at oms within and be tween each con for ma tion of the dis or dered butyl group were re strained to have sim i lar atomic
dis place ment pa ram e ters. The non-H-at oms were re fined anisotropically. The wa ter H-at oms of (R,R)-9a were
placed in the po si tions in di cated by a dif fer ence elec tron den sity map and their po si tions were al lowed to re fine to -
gether with in di vid ual iso tro pic dis place ment pa ram e ters and O–H dis tance re straints. All re main ing H-at oms of
(R,R)-9a and all H-at oms of (R,R)- and (S,S)-3c were placed in geo met ri cally cal cu lated po si tions and re fined us ing
a rid ing model where each H-atom was as signed a fixed iso tro pic dis place ment pa ram e ter with a value equal to
1.2Ueq of its par ent C-atom (1.5Ueq for the methyl groups). The re fine ment of each struc ture was car ried out on F 2
us ing full-ma trix least-squares pro ce dures, which min i mized the func tion Σw(Fo2– Fc2)2. Cor rec tions for sec ond ary
ex tinc tion were ap plied for (S,S)-3c and (R,R)-9a. Re fine ment of the ab so lute struc ture pa ram e ter [18] of (R,R)- and
(S,S)-3c yielded val ues of 0.02(7) and 0.1(1), re spec tively, which con fi dently con firms that the re fined mod els cor -
re spond with the true enantiomorph. The ab so lute con fig u ra tion for (R,R)-9a was cho sen to cor re spond with that
ex pected from the syn the sis. Neu tral atom scat ter ing fac tors for non-H-at oms were taken from [19a], and the scat -
ter ing fac tors for H-at oms were taken from [20]. Anom a lous dis per sion ef fects were in cluded in Fc [21]; the val ues
for f ′ and f ′′ were those of [19b]. The val ues of the mass attenuation co ef fi cients are those of [19c]. All cal cu la -
tions were per formed us ing the SHELXL97 [22] pro gram.
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*    CCDC-715753–715755 contain the supplementary crystallographic data for this paper.
   These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via
   www.ccdc.cam.ac.uk/data_request/cif.
Ta ble 1. Crys tal lo graphic data for com pounds (R,R)- and (S,S)-3c and (R,R)-9a.
(R,R)-3c         (S,S)-3c         (R,R)-9a               
Crys tal lized from hex ane/CH2Cl2 hex ane/CH2Cl2 MeOH
Em pir i cal for mula C37H34Cl2N4O2 C37H34Cl2N4O2 C34H48B2F8N4O
For mula weight [g mol–1] 637.61 637.61 702.39
Crys tal color, habit col or less, tab let col or less, nee dle  col or less, tab let
Crys tal di men sions [mm] 0.10 × 0.25 × 0.28 0.08 × 0.08 × 0.25 0.10 × 0.17 × 0.22
Tem per a ture [K] 160(1) 160(1) 160(1)
Crys tal sys tem monoclinic monoclinic monoclinic
Space group P21 P21 P21
Z 4 4 2
Re flec tions for cell de ter mi na tion 102503 34413 3301
2θ range for cell de ter mi na tion  [°] 4–50 4–50 4–50
Unit cell pa ram e ters a [Å] 13.6635(2) 13.6654(4) 11.0058(7)
                                 b [Å] 14.5032(2) 14.5289(4) 14.526(1)
                                 c [Å] 16.4739(2) 16.4467(3) 11.9131(5)
                                 β [°] 103.3716(9) 103.248(2) 108.960(4)
                                 V [Å3] 3176.04(8) 3178.5(2) 1801.2(2)
Dx [g cm–3] 1.333 1.332 1.295
µ(MoKα) [mm–1] 0.245 0.245 0.106
Scan type ω ω ω
2θ (max) [°] 50 50 50
Trans mis sion fac tors (min; max) 0.785; 0.963 0.954; 0.985 –
To tal re flec tions mea sured 47957 49399 23122
Sym me try in de pend ent re flec tions 11164 10722 3311
Re flec tions with I > 2σ(I) 8818 8289 2685
Re flec tions used in re fine ment 11164 10722 3311
Pa ram e ters re fined; re straints 811; 1 812; 1 493; 104
Fi nal R(F) [I > 2σ(I) re flec tions] 0.0545 0.0694 0.0746
         wR(F2)  (all data) 0.1433 0.1947 0.2212
Weights:a)  a; b 0.0693; 1.9356 0.1150; 2.0927 0.1496; 0.9576
Good ness of fit 1.024 1.027 1.041
Sec ond ary ex tinc tion co ef fi cient – 0.0032(8) 0.015(7)
Fi nal ∆max/σ 0.002 0.001 0.002
∆ρ (max; min) [e Å–3] 0.88; –0.51 1.48; –0.74 0.67; –0.49
a)w = [σ2(Fo2) + (aP)2 + bP]–1, where P = (Fo2 + 2Fc2)/3
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